Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
Background T cells engineered to express chimeric antigen receptors (CARs) have established efficacy in the treatment of B-cell malignancies, but their relevance in solid tumors remains undefined. Here we report results of the first human trials of CAR-T cells in the treatment of solid tumors perfor...
Saved in:
| Main Authors: | Jeffrey Schlom, Carl H. June, George A. Fisher, John J. Nemunaitis, Kristen M. Hege, Emily K. Bergsland, Robert S. Warren, James G. McArthur, Andy A. Lin, Stephen A. Sherwin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2017-01-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/5/1/22.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01) -
Chimeric Pneumoviridae fusion proteins as immunogens to induce cross‐neutralizing antibody responses
by: Eduardo Olmedillas, et al.
Published: (2017-12-01) -
Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation
by: Shaomei Feng, et al.
Published: (2025-06-01) -
Armoring chimeric antigen receptor (CAR) T cells as micropharmacies for cancer therapy
by: C. Carcopino, et al.
Published: (2024-12-01) -
Sex Differences in Outcomes of Chimeric Antigen Receptor (CAR) T‐Cell Therapy
by: Jia Yi Tan, et al.
Published: (2025-03-01)